Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
House dust mite allergens are proteins found in the feces and body parts of house dust mites. These allergens trigger IgE-mediated Type I hypersensitivity reactions, leading to symptoms of allergic rhinitis, asthma, and atopic dermatitis. Key allergens include Der p 1, Der f 1, Der p 2, Der f 2, and Der p 7. Der p 1 is a cysteine protease that disrupts epithelial barriers. Group 2 and 7 allergens share structural similarities with proteins involved in innate immunity pathways.
Antihistamines block histamine receptors to reduce allergy symptoms. Corticosteroids reduce inflammation. Immunotherapy desensitizes the individual by gradually increasing exposure to the allergen.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on House Dust Mite Allergen.